ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,193Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 212

$678K Total Retail Price of All Prescriptions

Rank: 8 out of 212

453 Patients Receiving at Least One Drug in Part D
98%Patients 65 Years and Older
18% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Hawaii
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

2% of this provider’s 453 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

0% of this provider’s 10,006 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $66 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Hawaii
AMLODIPINE BESYLATE 515 515 1 3
LOSARTAN-HYDROCHLOROTHIAZIDE 512 512 2 20
LOVASTATIN 509 495 3 12
PRAVASTATIN SODIUM 425 416 4 15
LOSARTAN POTASSIUM 343 339 5 4
LEVOTHYROXINE SODIUM 301 289 6 7
SIMVASTATIN 297 296 7 1
ATORVASTATIN CALCIUM 275 259 8 6
ALENDRONATE SODIUM 227 222 9 16
LISINOPRIL 201 200 10 2
OMEPRAZOLE 198 197 11 9
METOPROLOL SUCCINATE 190 190 12 14
DONEPEZIL HCL 171 171 13 25
METFORMIN HCL ER 165 165 14 34
CARVEDILOL 157 157 15 23
AMLODIPINE BESYLATE-BENAZEPRIL 155 144 16 30
NAMENDA 153 153 17 28
METFORMIN HCL 149 136 18 5
GLIPIZIDE 148 148 19 38
TAMSULOSIN HCL 147 147 20 21
FINASTERIDE 141 141 21 59
LISINOPRIL-HYDROCHLOROTHIAZIDE 138 138 22 24
JANUVIA 133 133 23 35
SYNTHROID 131 131 24 69
FUROSEMIDE 120 120 25 11
GLIMEPIRIDE 112 111 26 61
ADVAIR DISKUS 111 111 27 33
ALLOPURINOL 103 103 28 18
FLUTICASONE PROPIONATE 101 98 29 48
POLYETHYLENE GLYCOL 3350 93 88 30 91
EVISTA 92 92 31 49
DILTIAZEM 24HR ER 91 91 32 97
CRESTOR 90 90 33 51
FELODIPINE ER 78 78 34 36
ACTONEL 75 75 35 73
ATENOLOL 74 74 36 13
TRIAMTERENE-HCTZ 72 72 37 106
MIRTAZAPINE 71 71 38 43
HYDROCHLOROTHIAZIDE 68 68 39 8
BISOPROLOL-HYDROCHLOROTHIAZIDE 68 68 39 101
ZOLPIDEM TARTRATE 67 67 41 26
METOPROLOL TARTRATE 64 64 42 17
EXELON 58 58 43 86
TRIAMCINOLONE ACETONIDE 57 51 44 95
VERAPAMIL ER 55 55 45 99
LIPITOR 51 51 46 87
POTASSIUM CHLORIDE 50 50 47 27
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 11, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.